Search Results

You are looking at 1 - 10 of 186 items for :

  • Refine by Access: All Content x
Clear All

Introduction In 2019, there were estimated to be more than 27 million lifetime lysergic acid diethylamide (LSD) users in the United States (U.S.) ( Center for Behavioral Health Statistics and Quality, 2019a ). Use of LSD in the U.S. has more than

Open access

Introduction Colloquially known as “acid,” “Golden Dragon,” and “Yellow sunshine,” lysergic acid diethylamide (LSD) use is a health problem in the USA. Part of a broader class of drugs known as psychedelics or hallucinogens

Open access

have periodically reflected on my experiences with LSD since they were so transformative. The decision to write an account of my most powerful psychedelic encounters emerged in 2001, shortly after my mother’s death. The demise of a parent or close

Open access

Despite its current status as an illegal substance, lysergic acid diethylamide (LSD) has an extensive history of being the subject of scientific investigation into its potential therapeutic benefits. Originally synthesized from ergot fungus

Open access

disorder, suicidal ideation, and those who experience psychotic episodes in the setting of depression. Most of the early research with psychedelics focused on LSD. Initially, mescaline was primarily used, but when LSD was invented and made available it was

Open access

psychedelic-assisted therapy, focusing on LSD, in research or clinical contexts among first responders in Canada and the USA. Our preliminary results aim to inform the development of larger patient-oriented clinical trials and eventually the design of clinical

Open access

usage was condemned ( Schultes, Hofmann, & Rätsch, 1979 ). The laboratory study of hallucinogens began with Hofmann’s synthesis of lysergic acid diethylamide (LSD) in 1938. Since then, hallucinogen-assisted psychotherapy has been used to treat many

Open access

Introduction Hallucinogens, primarily lysergic acid diethylamide (LSD) and psilocybin, have been used for the treatment of anxiety and mood disturbance associated with terminal illnesses since as early as 1960, with four

Open access

-Assisted Psychotherapy? Following the discovery of the psychoactive effects of lysergic acid diethylamide (LSD) by Albert Hofmann in 1943, the compound was made available by Sandoz Pharmaceuticals to researchers with two explicit indications: to “elicit release

Open access

-addictive, and exerting profound effects on human consciousness. Examples of classical psychedelics include DMT, LSD, psilocybin, mescaline, and compounds of the 2C family. The tryptamine psychedelics such as DMT and psilocybin structurally resemble serotonin

Open access